SIGLEC1 and rheumatoid arthritis: In rheumatoid arthritis, a chronic autoinflammatory condition that affects the joints, circulating CD169+ monocytes and joint-resident CD169+ macrophages are increased and monocyte presence correlates with a worse prognosis [4,148,149,150].